International Stem Cell (ISCO) 10-Q2021 Q2 Quarterly report

Filed: 13 Aug 21, 4:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: assembly, bankruptcy, baseline, cease, criteria, damage, discontinuation, discontinue, disrupt, dropped, fabricate, factor, fill, half, harm, inability, Index, initial, initiating, insolvency, intellectual, interruption, labor, lead, levodopa, NaN, occurrence, package, packaging, permanent, post, procure, quickly, release, releasing, reliance, rely, reputation, resin, score, Secretary, shortage, sourcing, storage, tampering, theft, transit, trend, vendor

Removed: adjunctive, announced, apply, certification, cleared, cognitive, College, considerable, coordination, dataset, dated, demonstrated, Designation, displayed, dose, duly, dysfunction, efficacy, eligibility, enrollment, establishing, evidence, Exhibit, extreme, Florida, forgiven, garnette, herewith, highest, important, incorporated, intend, investigational, ischemic, journal, July, launch, logical, made, mechanism, Medicine, meeting, minimal, Morsani, motor, multiple, neurological, Neuroscience, patient, policy, Preliminary, primate, profile, promote, publication, published, reference, regenerative, registrant, remodeling, Restated, rodent, ruling, Section, sophia, South, Specimen, step, thereunto, Title, titled, transplanted, treated, Tulane, undersigned, University, vehicle, wholly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ISCO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of International Stem Cell Corporation (the “Company”) for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Andrey Semechkin, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 13, 2021

By:	/s/ Andrey Semechkin
	Andrey Semechkin
	Chief Executive Officer
	(Principal Executive Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.